Photodynamic therapy (PDT) exploits light-activated compounds for therapeutic use. It relies
on a photosensitiser (PS) that is inactive in the absence of light. When irradiated, the PS …

Recently, diverse functional materials that take subcellular structures as therapeutic targets
are playing increasingly important roles in cancer therapy. Here, particular emphasis is …

Photodynamic therapy (PDT) is a promising approach for treatment of cancer and bacterial
infection. Upon excitation by light, photosensitizers (PSs) produce reactive oxygen species …

Ruthenium (II) polypyridine complexes are one of the most extensively studied and
developed systems in the family of luminescent transition-metal complexes. Notably, there …

Among all molecules developed for anticancer therapies, photodynamic therapeutic agents
have a unique profile. Their maximal activity is specifically triggered in tumors by light, and …

In this experimental approach, we explored the structures, morphologies, phototoxicities,
and antibacterial activities of undoped and Mn‐doped ceria nanocomposite materials …

The emergence of antimicrobial drug resistance requires development of alternative
therapeutic options. Multidrug-resistant strains of Enterococcus spp., Staphylococcus …

The synthesis, photophysics, and photobiological activities of a series of novel neutral
heteroleptic cyclometalated iridium (III) complexes incorporating boron dipyrromethene …

Photocatalytic compounds and complexes, such as tris (bipyridine) ruthenium (II),[Ru (bpy)
3] 2+, have recently attracted attention as light-mediated bactericides that can help to …

Abstract Three new bis (2, 2′‐bipyridine)‐heteroleptic Ru (II) dyads incorporating thienyl
groups (n= 1–3, compounds 1, 2 and 3, respectively) appended to 1, 10‐phenanthroline …